{
    "Trade/Device Name(s)": [
        "Fastep\u2122 At-Home Pregnancy Test",
        "FastepTM At-Home Pregnancy Tests"
    ],
    "Submitter Information": "Polymed Therapeutics, Inc.",
    "510(k) Number": "k122907",
    "Predicate Device Reference 510(k) Number(s)": [
        "k974059"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "March 14, 2013",
    "Summary Letter Received Date": "February 07, 2013",
    "Submission Date": "January 31, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (HCG) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay"
    ],
    "Methodologies": [
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Kit",
        "Strip",
        "Device"
    ],
    "Document Summary": "FDA 510(k) summary for Fastep At-Home Pregnancy Test, a rapid chromatographic immunoassay for qualitative detection of hCG in urine for OTC early pregnancy determination.",
    "Indications for Use Summary": "A rapid chromatographic immunoassay for the visual, qualitative detection of human chorionic gonadotropin (hCG) in urine specimen to aid in the early detection of pregnancy; intended for OTC use.",
    "fda_folder": "Clinical Chemistry"
}